- Home
- PYPD vs AMPG Comparison
PYPD vs AMPG Comparison
Compare PYPD & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- AMPG
- Stock Information
- Founded
- PYPD 2008
- AMPG 2002
- Country
- PYPD Israel
- AMPG United States
- Employees
- PYPD N/A
- AMPG N/A
- Industry
- PYPD Medical/Dental Instruments
- AMPG Telecommunications Equipment
- Sector
- PYPD Health Care
- AMPG Telecommunications
- Exchange
- PYPD Nasdaq
- AMPG Nasdaq
- Market Cap
- PYPD 30.1M
- AMPG 29.7M
- IPO Year
- PYPD 2020
- AMPG N/A
- Fundamental
- Price
- PYPD $2.75
- AMPG $1.49
- Analyst Decision
- PYPD Strong Buy
- AMPG Strong Buy
- Analyst Count
- PYPD 2
- AMPG 1
- Target Price
- PYPD $10.50
- AMPG $5.00
- AVG Volume (30 Days)
- PYPD 13.1K
- AMPG 274.5K
- Earning Date
- PYPD 05-07-2025
- AMPG 04-08-2025
- Dividend Yield
- PYPD N/A
- AMPG N/A
- EPS Growth
- PYPD N/A
- AMPG N/A
- EPS
- PYPD N/A
- AMPG N/A
- Revenue
- PYPD N/A
- AMPG $11,667,163.00
- Revenue This Year
- PYPD N/A
- AMPG N/A
- Revenue Next Year
- PYPD N/A
- AMPG $58.88
- P/E Ratio
- PYPD N/A
- AMPG N/A
- Revenue Growth
- PYPD N/A
- AMPG N/A
- 52 Week Low
- PYPD $2.37
- AMPG $0.64
- 52 Week High
- PYPD $5.09
- AMPG $6.43
- Technical
- Relative Strength Index (RSI)
- PYPD 42.15
- AMPG 40.96
- Support Level
- PYPD $2.66
- AMPG $1.52
- Resistance Level
- PYPD $2.97
- AMPG $1.91
- Average True Range (ATR)
- PYPD 0.14
- AMPG 0.14
- MACD
- PYPD -0.02
- AMPG -0.00
- Stochastic Oscillator
- PYPD 8.86
- AMPG 25.49
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.